NFKB1 and pachyonychia congenita: Indeed, there is recent evidence that IL-6 exposure (an NFκB target gene product) induces neuroendocrine differentiation of PC tumour sub-clones, conveying anti-apoptotic phenotype and resistance to chemotherapy [4,5].